{"id":"https://openalex.org/W2989409772","doi":"https://doi.org/10.1182/blood-2019-123126","title":"Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression Regimen","display_name":"Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression Regimen","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2989409772","doi":"https://doi.org/10.1182/blood-2019-123126","mag":"2989409772"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-123126","doi":"https://doi.org/10.1182/blood-2019-123126","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-123126","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049250527","display_name":"Katerina Pavenski","orcid":"https://orcid.org/0000-0001-6700-5197","observed_orcids":["https://orcid.org/0000-0001-6700-5197"]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Katerina Pavenski","raw_affiliation_strings":["Departments of Medicine and Laboratory Medicine, St. Michael's Hospital and University of Toronto, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Laboratory Medicine, St. Michael's Hospital and University of Toronto, Toronto, Canada","institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112136056","display_name":"Paul Kn\u00f6bl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Paul Knoebl","raw_affiliation_strings":["Department of Medicine 1, Division of Hematology and Hemostasis, Medical University of Vienna, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine 1, Division of Hematology and Hemostasis, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061278813","display_name":"Marie Scully","orcid":"https://orcid.org/0000-0002-2443-6517","observed_orcids":["https://orcid.org/0000-0002-2443-6517"]},"institutions":[{"id":"https://openalex.org/I1340918713","display_name":"University College London Hospitals NHS Foundation Trust","ror":"https://ror.org/042fqyp44","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713"]},{"id":"https://openalex.org/I34931013","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08","country_code":"GB","type":"government","lineage":["https://openalex.org/I34931013"]},{"id":"https://openalex.org/I4210138523","display_name":"UCL Biomedical Research Centre","ror":"https://ror.org/03r9qc142","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I124357947","https://openalex.org/I1340918713","https://openalex.org/I34931013","https://openalex.org/I4210138523","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Marie Scully","raw_affiliation_strings":["Department of Haematology, University College London Hospitals, Cardiometabolic Programme, National Institute for Health Research UCLH-UCL Biomedical Research Center, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, University College London Hospitals, Cardiometabolic Programme, National Institute for Health Research UCLH-UCL Biomedical Research Center, London, United Kingdom","institution_ids":["https://openalex.org/I1340918713","https://openalex.org/I34931013","https://openalex.org/I4210138523","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067149049","display_name":"Johanna A. Kremer Hovinga","orcid":"https://orcid.org/0000-0002-1300-7135","observed_orcids":["https://orcid.org/0000-0002-1300-7135"]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]},{"id":"https://openalex.org/I2801112126","display_name":"University Hospital of Bern","ror":"https://ror.org/01q9sj412","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2801112126"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Johanna A. Kremer Hovinga","raw_affiliation_strings":["Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland","institution_ids":["https://openalex.org/I118564535","https://openalex.org/I2801112126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041549015","display_name":"Paul Coppo","orcid":"https://orcid.org/0000-0002-4618-2095","observed_orcids":["https://orcid.org/0000-0002-4618-2095"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Paul Coppo","raw_affiliation_strings":["Department of Hematology, Reference Center for Thrombotic Microangiopathies (CNR-MAT), Saint-Antoine University Hospital, AP-HP, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Reference Center for Thrombotic Microangiopathies (CNR-MAT), Saint-Antoine University Hospital, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061651325","display_name":"Flora Peyvandi","orcid":"https://orcid.org/0000-0001-7423-9864","observed_orcids":["https://orcid.org/0000-0001-7423-9864"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I2803066834","display_name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","ror":"https://ror.org/016zn0y21","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I2803066834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Flora Peyvandi","raw_affiliation_strings":["Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, and Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, and Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I2803066834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053638396","display_name":"Spero R. Cataland","orcid":"https://orcid.org/0000-0001-8977-6910","observed_orcids":["https://orcid.org/0000-0001-8977-6910"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spero Cataland","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020318774","display_name":"Ara D. Metjian","orcid":"https://orcid.org/0000-0001-9890-8639","observed_orcids":["https://orcid.org/0000-0001-9890-8639"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ara Metjian","raw_affiliation_strings":["Department of Medicine, Duke University School of Medicine, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Duke University School of Medicine, Durham, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032722606","display_name":"Javier de la Rubia","orcid":"https://orcid.org/0000-0002-8354-768X","observed_orcids":["https://orcid.org/0000-0002-8354-768X"]},"institutions":[{"id":"https://openalex.org/I4210126200","display_name":"Hospital Universitario Doctor Peset","ror":"https://ror.org/03971n288","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210126200"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier De La Rubia","raw_affiliation_strings":["Hematology Department, Internal Medicine, School of Medicine and Dentistry, Catholic University of Valencia and Hospital Doctor Peset, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Internal Medicine, School of Medicine and Dentistry, Catholic University of Valencia and Hospital Doctor Peset, Valencia, Spain","institution_ids":["https://openalex.org/I4210126200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069541959","display_name":"Hilde A.M. De Winter","orcid":"https://orcid.org/0000-0002-5153-4315","observed_orcids":["https://orcid.org/0000-0002-5153-4315"]},"institutions":[{"id":"https://openalex.org/I124674891","display_name":"Ablynx (Belgium)","ror":"https://ror.org/05s030550","country_code":"BE","type":"company","lineage":["https://openalex.org/I124674891"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Hilde De Winter","raw_affiliation_strings":["Formerly Clinical Development, Ablynx, a Sanofi company, Ghent, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Formerly Clinical Development, Ablynx, a Sanofi company, Ghent, Belgium","institution_ids":["https://openalex.org/I124674891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023779315","display_name":"Rui de Passos Sousa","orcid":"https://orcid.org/0000-0001-8378-723X","observed_orcids":["https://orcid.org/0000-0001-8378-723X"]},"institutions":[{"id":"https://openalex.org/I4405253000","display_name":"Sanofi (Portugal)","ror":"https://ror.org/00704c791","country_code":"PT","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4405253000"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Rui de Passos Sousa","raw_affiliation_strings":["Medical Affairs, Sanofi, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs, Sanofi, Lisbon, Portugal","institution_ids":["https://openalex.org/I4405253000"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076737277","display_name":"Filip Callewaert","orcid":"https://orcid.org/0000-0002-5441-5338","observed_orcids":["https://orcid.org/0000-0002-5441-5338"]},"institutions":[{"id":"https://openalex.org/I4210123153","display_name":"Sanofi (Belgium)","ror":"https://ror.org/02wnz8673","country_code":"BE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210123153"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Filip Callewaert","raw_affiliation_strings":["Medical Affairs, Sanofi, Diegem, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs, Sanofi, Diegem, Belgium","institution_ids":["https://openalex.org/I4210123153"]}]}],"institutions":[],"countries_distinct_count":10,"institutions_distinct_count":20,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"2365","last_page":"2365"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acquired-thrombotic-thrombocytopenic-purpura","display_name":"acquired thrombotic thrombocytopenic purpura","score":0.9430000185966492},{"id":"https://openalex.org/keywords/caplacizumab","display_name":"caplacizumab","score":0.9879999756813049},{"id":"https://openalex.org/keywords/immunosuppressive-regimens","display_name":"immunosuppressive regimens","score":0.8700000047683716},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.9430000185966492},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/therapeutic-plasma-exchange","display_name":"plasma exchange","score":0.6859999895095825},{"id":"https://openalex.org/keywords/adamts13","display_name":"ADAMTS13","score":0.8339999914169312},{"id":"https://openalex.org/keywords/von-willebrand-factor","display_name":"von Willebrand factor","score":0.7940000295639038},{"id":"https://openalex.org/keywords/thrombotic-microangiopathy","display_name":"thrombotic microangiopathy","score":0.7570000290870667},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.44699999690055847},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.5630000233650208},{"id":"https://openalex.org/keywords/platelet-count-response","display_name":"platelet count response","score":0.7139999866485596},{"id":"https://openalex.org/keywords/thromboembolic-events","display_name":"thromboembolic events","score":0.8220000267028809}],"concepts":[{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.7986417412757874},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7789729833602905},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.737895131111145},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6943398714065552},{"id":"https://openalex.org/C2777878052","wikidata":"https://www.wikidata.org/wiki/Q3312044","display_name":"Thrombotic microangiopathy","level":3,"score":0.6229332089424133},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6154395341873169},{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.48479002714157104},{"id":"https://openalex.org/C128057223","wikidata":"https://www.wikidata.org/wiki/Q420566","display_name":"Calcineurin","level":3,"score":0.4584767818450928},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4258239269256592},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3582296371459961},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34921300411224365},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.20788666605949402},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-123126","doi":"https://doi.org/10.1182/blood-2019-123126","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-123126","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2904119070","https://openalex.org/W2905955227","https://openalex.org/W7131663798","https://openalex.org/W2911065823","https://openalex.org/W3212235981","https://openalex.org/W3094834921","https://openalex.org/W2987257444","https://openalex.org/W2986287556","https://openalex.org/W4400698052","https://openalex.org/W3033226539"],"abstract_inverted_index":{"Background:":[0],"Acquired":[1],"thrombotic":[2,10,540],"thrombocytopenic":[3],"purpura":[4],"(aTTP)":[5],"is":[6],"an":[7,69,82,686,698,713,727],"acute,":[8],"life-threatening":[9],"microangiopathy":[11],"that":[12,452],"requires":[13,531],"urgent":[14],"and":[15,45,108,118,205,218,226,269,295,365,377,403,423,542,549],"specialized":[16],"treatment.":[17],"Prior":[18],"to":[19,36,47,74,114,159,172,198,399,447,524,533,539,564,614,627,642,656,669],"the":[20,24,86,94,112,120,141,155,167,173,188,202,245,250,273,278,308,324,329,391,413,416,428,439,468,485,489,496,507,526,553],"introduction":[21],"of":[22,63,72,93,122,126,143,169,179,190,201,224,277,286,353,390,393,415,419,433,516,552,555,620,633,648,662,675,689,701,716,730],"caplacizumab,":[23],"treatment":[25,203,322,382,430,486,510,545],"for":[26,561],"aTTP":[27,64,388,522],"was":[28,151,163],"based":[29,186],"on":[30,85,187,347,371,397,685,697,712,726],"daily":[31],"therapeutic":[32],"plasma":[33],"exchange":[34],"(TPE;":[35],"replenish":[37],"functional":[38],"ADAMTS13":[39],"enzyme)":[40],"plus":[41,498],"immunosuppression":[42,147,175,192,288,305,435,557],"(mainly":[43],"corticosteroids":[44,216,225,258,268,291,299,348,372],"rituximab;":[46],"suppress":[48],"anti-ADAMTS13":[49],"autoantibody":[50],"production).":[51],"TPE":[52,107],"combined":[53,222],"with":[54,68,106,373,387,454],"immunosuppressive":[55,261,321,562],"therapy":[56,195,339,520,563],"improved":[57,383],"outcomes":[58,384,405],"in":[59,104,153,166,182,229,239,249,307,342,366,385,408,438,444,475,488,495,521],"patients;":[60],"however,":[61],"episodes":[62],"are":[65,406,458],"still":[66],"associated":[67],"acute":[70],"mortality":[71],"up":[73,197],"20%":[75],"as":[76,259],"these":[77],"therapies":[78],"do":[79],"not":[80,235,318,459],"have":[81],"immediate":[83],"effect":[84],"pathologic":[87],"microvascular":[88],"thrombosis.":[89],"The":[90,208],"primary":[91],"results":[92],"randomized,":[95],"double-blind,":[96],"placebo-controlled":[97],"phase":[98],"3":[99,200,275,367],"HERCULES":[100,183,251],"study":[101,309,469,508],"showed":[102],"that,":[103],"combination":[105],"corticosteroids,":[109,453],"caplacizumab":[110,170,474],"shortened":[111],"time":[113,398,532,560],"platelet":[115,400],"count":[116,401],"response":[117,402],"reduced":[119,412,472],"incidence":[121],"a":[123,221,448,769,782],"composite":[124,417],"outcome":[125],"TTP-related":[127,420],"death,":[128,421,550],"exacerbation,":[129,422],"or":[130,231,455,465,691,703,718,732],"major":[131,424],"thromboembolic":[132,425],"events,":[133],"by":[134,473,780],"inhibiting":[135],"vWF-platelet":[136],"interaction":[137],"and,":[138],"thereby,":[139],"stopping":[140],"formation":[142],"microthrombi.":[144],"As":[145],"additional":[146],"per":[148],"local":[149],"practice":[150],"permitted":[152],"HERCULES,":[154],"present":[156],"analysis":[157],"aimed":[158],"determine":[160],"whether":[161],"there":[162],"any":[164,320],"difference":[165],"efficacy":[168],"according":[171],"initial":[174,287,394,556],"regimen.":[176,436],"Methods:":[177],"Data":[178,396],"patients":[180,248,255,266,281,315,344,368,386,482,538],"participating":[181],"were":[184,213,234,333,470],"stratified":[185],"type":[189,285,392,515,554],"first-line":[191,260],"regimen":[193,223],"(i.e.":[194],"started":[196,304],"Day":[199],"period)":[204],"analyzed":[206,212],"descriptively.":[207],"main":[209,330],"2":[210,331],"groups":[211],"those":[214,219],"receiving":[215,220,513],"only":[217,257,491],"rituximab.":[227],"Differences":[228],"dose":[230],"dosing":[232],"frequency":[233],"taken":[236],"into":[237],"consideration":[238],"this":[240,536],"descriptive":[241],"analysis.":[242],"Results:":[243],"Of":[244],"145":[246],"randomized":[247],"study,":[252],"112":[253],"(77.2%)":[254],"received":[256,267,283],"therapy,":[262],"while":[263,313,512],"24":[264],"(16.6%)":[265],"rituximab":[270,354,374,499],"(initiated":[271],"within":[272],"first":[274],"days":[276],"study).":[279],"Three":[280],"(2.1%)":[282],"another":[284,514],"(cyclophosphamide":[289,310],"+":[290,298,311],"[n=1],":[292,294,361],"hydroxychloroquine":[293],"mycophenolate":[296,362,378],"mofetil":[297,363,379],"[n=1]),":[300,364],"1":[301],"patient":[302,504],"(0.7%)":[303],"later":[306],"corticosteroids),":[312],"5":[314],"(3.4%)":[316],"did":[317],"receive":[319],"during":[323,427,467,484,506],"study.":[325],"Baseline":[326],"characteristics":[327],"between":[328],"subgroups":[332,446,477],"well":[334],"balanced":[335],"(Table":[336,478],"1).":[337],"Immunosuppressive":[338,519],"intensification":[340],"occurred":[341,443],"38":[343],"(33.9%)":[345],"initiated":[346,370],"alone":[349],"(most":[350],"often":[351],"addition":[352],"[n=37],":[355],"others":[356],"included":[357],"splenectomy":[358],"[n=2],":[359],"bortezomib":[360],"(12.5%)":[369],"(bortezomib":[375],"[n=1]":[376],"[n=3]).":[380],"Caplacizumab":[381,411,544],"irrespective":[389,432,551],"immunosuppression.":[395],"clinical":[404],"summarized":[407],"Table":[409],"2.":[410],"rate":[414],"endpoint":[418],"events":[426],"double-blind":[429],"period":[431,487,511],"baseline":[434],"Notably,":[437],"placebo":[440,481,503],"arm,":[441],"exacerbations":[442,548],"both":[445,476],"similar":[449],"extent,":[450],"indicating":[451],"without":[456],"rituximab,":[457],"immediately":[460],"effective.":[461],"Overall,":[462],"recurrences":[463],"(exacerbations":[464],"relapses)":[466],"also":[471],"2).":[479],"Two":[480],"died":[483,505],"corticosteroid":[490,497],"subgroup":[492,500],"versus":[493],"none":[494],"(one":[501],"other":[502],"drug":[509],"immunosuppression).":[517],"Conclusion:":[518],"aims":[523],"control":[525],"underlying":[527],"autoimmune":[528],"disease,":[529],"but":[530],"take":[534,565],"effect;":[535],"exposes":[537],"complications":[541],"death.":[543],"prevents":[546],"disease":[547],"used,":[558],"allowing":[559],"effect.":[566],"Disclosures":[567],"Pavenski:":[568],"Ablynx:":[569],"Honoraria,":[570,576,610,638,652,665,695,724],"Research":[571,577,580,583,587,598,635,736,740,744,748,752],"Funding;":[572,578,581,588,599,636,741,749],"Shire:":[573,622],"Honoraria;":[574,707,709,722],"Alexion:":[575,600,681,742],"Octapharma:":[579,735],"Bioverativ:":[582,710],"Funding.":[584,737,745,753],"Knoebl:Novo-Nordisk:":[585],"Consultancy,":[586,623,651,739,743,747,751],"Ablynx/Sanofi:":[589,602,650,679],"Consultancy;":[590,592,594,601,603,605,678,680,758,760,762,764],"CSL-Behring:":[591,637],"Shire/Takeda:":[593,604],"Roche:":[595,664,694],"Consultancy.":[596,607,682,766],"Scully:Shire:":[597],"Novartis:":[606],"Kremer":[608],"Hovinga:Siemens:":[609],"Other:":[611,624,639,653,666],"Honoraria":[612,625,640,654,667],"go":[613,626,641,655,668],"employer":[615,628,643,657,670],"(Insel":[616,629,644,658,671],"Gruppe":[617,630,645,659,672],"AG,":[618,631,646,660,673],"Department":[619,632,647,661,674],"Hematology);":[621,649,663],"Hematology),":[634],"Hematology).":[676],"Coppo:Shire:":[677],"Peyvandi:Sanofi:":[683],"Membership":[684,696,711,725],"entity's":[687,699,714,728],"Board":[688,700,715,729],"Directors":[690,702,717,731],"advisory":[692,704,719,733],"committees;":[693,705,720,734],"Grifols:":[706],"Kedrion:":[708],"Alnylam:":[721],"Takeda:":[723,761],"Cataland:Ablynx/Sanofi:":[738],"Metjian:Genentech:":[746],"AblynxNV/Sanofi:":[750],"De":[754,767],"La":[755],"Rubia:Celgene":[756],"Corporation:":[757],"AbbVie:":[759],"AMGEN:":[763],"Janssen:":[765],"Winter:Ablynx,":[768],"Sanofi":[770,783],"company:":[771],"Employment.":[772,776,785],"de":[773],"Passos":[774],"Sousa:Sanofi:":[775],"Callewaert:Sanofi":[777],"(formerly":[778],"employed":[779],"Ablynx,":[781],"company):":[784]},"counts_by_year":[{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2019-11-22T00:00:00"}